NuCana plc EBIT

NuCana plc (NCNA) currently reports a EBIT of $-24M as of March 2026. That compares with $-17M in the prior-year period — down 40.8% year over year. That is below the Healthcare sector average of $22B. Use the charts on this page to explore NuCana plc's EBIT history and peer comparisons.

NuCana plc's EBIT decreased from $-17M to $-24M — a 40.8% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

NuCana plc's EBIT of $-24M is lower than the Healthcare sector average of $22B. That is roughly 100.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

NuCana plc reported $-24M in EBIT as of March 2026. That compares with $-17M in the prior-year period — down 40.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-24M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $22B. From there, open related valuation or income-statement pages for NuCana plc, and consider following NCNA for alerts when major investors trade the stock.